Literature DB >> 21629123

Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce.

Kathleen R Blazer1, Deborah J Macdonald, Julie O Culver, Carin R Huizenga, Robert J Morgan, Gwen C Uman, Jeffrey N Weitzel.   

Abstract

PURPOSE: To assess the impact of a multimodal interdisciplinary course on genetic cancer risk assessment and research collaboration for community-based clinicians. Clinicians are increasingly requested to conduct genetic cancer risk assessment, but many are inadequately prepared to provide these services.
METHODS: A prospective analysis of 131 participants (48 physicians, 41 advanced-practice nurses, and 42 genetic counselors) from community settings across the United States. The course was delivered in three phases: distance didactic learning, face-to-face training, and 12 months of web-based professional development activities to support integration of skills into practice. Cancer genetics knowledge, skills, professional self-efficacy, and practice changes were measured at baseline, immediate, and 14 months postcourse.
RESULTS: Knowledge, skills, and self-efficacy scores were significantly different between practice disciplines; however, postscores increased significantly overall and for each discipline (P < 0.001). Fourteen-month practice outcomes reflect significant increases in provision of genetic cancer risk assessment services (P = 0.018), dissemination of cancer prevention information (P = 0.005) and high-risk screening recommendations (P = 0.004) to patients, patient enrollment in research (P = 0.013), and educational outreach about genetic cancer risk assessment (P = 0.003).
CONCLUSIONS: Results support the efficacy of the multimodal course as a tool to develop a genetically literate workforce. Sustained alumni participation in web-based professional development activities has evolved into a distance-mediated community of practice in clinical cancer genetics, modeling the lifelong learning goals envisioned by leading continuing medical education stakeholders.

Entities:  

Mesh:

Year:  2011        PMID: 21629123      PMCID: PMC3337331          DOI: 10.1097/GIM.0b013e31821882b7

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  35 in total

1.  Development of a cancer genetics education program for clinicians.

Authors:  Kathleen R Blazer; Marcia Grant; Sharon R Sand; Deborah J MacDonald; Jeanne J Choi; Raluca A Nedelcu; Jeffrey N Weitzel
Journal:  J Cancer Educ       Date:  2002       Impact factor: 2.037

2.  Accreditation: standards for quality continuing professional development.

Authors:  James C Leist
Journal:  J Vet Med Educ       Date:  2003       Impact factor: 1.027

3.  Genes on the Web--direct-to-consumer marketing of genetic testing.

Authors:  Adam J Wolfberg
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

4.  An agenda for personalized medicine.

Authors:  Pauline C Ng; Sarah S Murray; Samuel Levy; J Craig Venter
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

5.  How doctors learn: the role of clinical problems across the medical school-to-practice continuum.

Authors:  H B Slotnick
Journal:  Acad Med       Date:  1996-01       Impact factor: 6.893

6.  The assessment and predictive generality of self-percepts of efficacy.

Authors:  A Bandura
Journal:  J Behav Ther Exp Psychiatry       Date:  1982-09

7.  Healthcare's ascension to patient-centered genomic care.

Authors:  Steven Ar Murphy; Jeffrey S Freed
Journal:  Per Med       Date:  2008-09       Impact factor: 2.512

8.  A meta-analysis of continuing medical education effectiveness.

Authors:  Maliheh Mansouri; Jocelyn Lockyer
Journal:  J Contin Educ Health Prof       Date:  2007       Impact factor: 1.355

9.  Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?

Authors:  D Davis; M A O'Brien; N Freemantle; F M Wolf; P Mazmanian; A Taylor-Vaisey
Journal:  JAMA       Date:  1999-09-01       Impact factor: 56.272

10.  Use of communities of practice in business and health care sectors: a systematic review.

Authors:  Linda C Li; Jeremy M Grimshaw; Camilla Nielsen; Maria Judd; Peter C Coyte; Ian D Graham
Journal:  Implement Sci       Date:  2009-05-17       Impact factor: 7.327

View more
  18 in total

1.  Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs.

Authors:  Carin R Espenschied; Deborah J MacDonald; Julie O Culver; Sharon Sand; Karen Hurley; Kimberly C Banks; Jeffrey N Weitzel; Kathleen R Blazer
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

2.  Physician Risk Assessment Knowledge Regarding BRCA Genetics Testing.

Authors:  Jason Cohn; William Blazey; David Tegay; Brian Harper; Sharon Koehler; Brookshield Laurent; Vivian Chan; Min-Kyung Jung; Bhuma Krishnamachari
Journal:  J Cancer Educ       Date:  2015-09       Impact factor: 2.037

3.  Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

Authors:  Jeffrey N Weitzel; Jessica Clague; Arelis Martir-Negron; Raquel Ogaz; Josef Herzog; Charité Ricker; Chelsy Jungbluth; Cheryl Cina; Paul Duncan; Gary Unzeitig; J Salvador Saldivar; Mary Beattie; Nancy Feldman; Sharon Sand; Danielle Port; Deborah I Barragan; Esther M John; Susan L Neuhausen; Garrett P Larson
Journal:  J Clin Oncol       Date:  2012-12-10       Impact factor: 44.544

4.  Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution.

Authors:  Ian K Komenaka; Jesse N Nodora; Lisa Madlensky; Lisa M Winton; Meredith A Heberer; Richard B Schwab; Jeffrey N Weitzel; Maria Elena Martinez
Journal:  J Community Genet       Date:  2015-12-21

Review 5.  Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Authors:  Jeffrey N Weitzel; Kathleen R Blazer; Deborah J MacDonald; Julie O Culver; Kenneth Offit
Journal:  CA Cancer J Clin       Date:  2011-08-19       Impact factor: 508.702

6.  Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.

Authors:  Allison H West; Kathleen R Blazer; Jessica Stoll; Matthew Jones; Caroline M Weipert; Sarah M Nielsen; Sonia S Kupfer; Jeffrey N Weitzel; Olufunmilayo I Olopade
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

7.  Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.

Authors:  J O Culver; C D Brinkerhoff; J Clague; K Yang; K E Singh; S R Sand; J N Weitzel
Journal:  Clin Genet       Date:  2013-02-20       Impact factor: 4.438

8.  Evolution of Hereditary Breast Cancer Genetic Services: Are Changes Reflected in the Knowledge and Clinical Practices of Florida Providers?

Authors:  Deborah Cragun; Courtney Scherr; Lucia Camperlengo; Susan T Vadaparampil; Tuya Pal
Journal:  Genet Test Mol Biomarkers       Date:  2016-08-15

9.  A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.

Authors:  Tuya Pal; Deborah Cragun; Courtney Lewis; Andrea Doty; Maria Rodriguez; Cristi Radford; Zachary Thompson; Jongphil Kim; Susan T Vadaparampil
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-28

10.  Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings.

Authors:  Kathleen R Blazer; Bita Nehoray; Ilana Solomon; Mariana Niell-Swiller; Julie O Culver; Gwen C Uman; Jeffrey N Weitzel
Journal:  Genet Test Mol Biomarkers       Date:  2015-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.